Analyzing SANUWAVE Health (OTCMKTS:SNWV) and IceCure Medical (NASDAQ:ICCM)

IceCure Medical (NASDAQ:ICCM) and SANUWAVE Health (OTCMKTS:SNWV) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, valuation, risk, analyst recommendations and earnings.

Volatility and Risk

IceCure Medical has a beta of 0.37, suggesting that its share price is 63% less volatile than the S&P 500. Comparatively, SANUWAVE Health has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500.

Earnings & Valuation

This table compares IceCure Medical and SANUWAVE Health”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.67 million	19.65	-$14.65 million	($0.29)	-4.48
SANUWAVE Health	$20.40 million	10.99	-$25.81 million	$8.32	3.16

IceCure Medical has higher earnings, but lower revenue than SANUWAVE Health. IceCure Medical is trading at a lower price-to-earnings ratio than SANUWAVE Health, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current recommendations and price targets for IceCure Medical and SANUWAVE Health, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	0	0	1	1	3.50
SANUWAVE Health	0	0	0	0	0.00

IceCure Medical presently has a consensus target price of $2.70, indicating a potential upside of 107.69%. Given IceCure Medical’s stronger consensus rating and higher possible upside, analysts clearly believe IceCure Medical is more favorable than SANUWAVE Health.

Insider & Institutional Ownership

0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 42.5% of SANUWAVE Health shares are held by institutional investors. 2.4% of IceCure Medical shares are held by insiders. Comparatively, 36.6% of SANUWAVE Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares IceCure Medical and SANUWAVE Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-376.85%	-124.44%	-87.70%
SANUWAVE Health	-1.33%	-23.83%	-20.70%

Summary

SANUWAVE Health beats IceCure Medical on 9 of the 15 factors compared between the two stocks.

About IceCure Medical

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

About SANUWAVE Health

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide solution for pain management in sports medicine and physical therapy. Its portfolio of wound treatment solutions provides patients with a noninvasive technology that boosts the body's normal healing and tissue regeneration processes. In addition, the company offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. SANUWAVE Health, Inc. was founded in 2004 and is headquartered in Eden Prairie, Minnesota.